Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10368-35-1

Post Buying Request

10368-35-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10368-35-1 Usage

Type of compound

Acetyl chloride derivative

Substituent group

4-ethoxyphenyl

Physical state

Colorless to pale yellow liquid

Odor

Pungent

Usage

Reagent in organic synthesis (preparation of pharmaceuticals and agrochemicals), building block in compound production, intermediate in chemical manufacturing processes

Hazards

Flammable, corrosive (requires careful handling in a controlled environment)

Check Digit Verification of cas no

The CAS Registry Mumber 10368-35-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,3,6 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 10368-35:
(7*1)+(6*0)+(5*3)+(4*6)+(3*8)+(2*3)+(1*5)=81
81 % 10 = 1
So 10368-35-1 is a valid CAS Registry Number.

10368-35-1Relevant articles and documents

C1 substituted 3, 4 - ISO-quinoline alkaloids of the preparation and its medicinal use

-

, (2019/03/28)

The invention belongs to the field of medical technology. The invention relates to a structure of the formula (I) indicated by the C1 substituted 3, 4 - ISO alkaloid or its pharmaceutically acceptable salt preparation method and medical use thereof. The invention to BOC - L - phenylalanine as raw materials, with 3, 4 - dimethoxyphenethylamine to N - acylated condensation and then remove the BOC group gets the (S)- 2 - amino - N - (3, 4 - dimethyl practiced with ethyl) - 3 - benzyl amide intermediate 1, intermediate 1 or phenethylamine derivatives with the prepared containing different substituent phenyllacetyl carries out amidation reaction, finally loop Bischler - Napieralski reaction. After activeness screening tests, the compounds of this invention possess pancrelipase inhibition, in the development into a lipase inhibitor and for preventing or treating hyperlipidemia, diabetes, obesity or metabolic syndrome and other diseases has a good application prospect.

COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES

-

Paragraph 00410-00411, (2019/03/12)

The present disclosure relates to compounds according to Formula (I), useful for treating diseases.

Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies

Bezen?on, Olivier,Heidmann, Bibia,Siegrist, Romain,Stamm, Simon,Richard, Sylvia,Pozzi, Davide,Corminboeuf, Olivier,Roch, Catherine,Kessler, Melanie,Ertel, Eric A.,Reymond, Isabelle,Pfeifer, Thomas,De Kanter, Ruben,Toeroek-Schafroth, Michael,Moccia, Luca G.,Mawet, Jacques,Moon, Richard,Rey, Markus,Capeleto, Bruno,Fournier, Elvire

supporting information, p. 9769 - 9789 (2017/12/26)

We report here the discovery and pharmacological characterization of N-(1-benzyl-1H-pyrazol-3-yl)-2-phenylacetamide derivatives as potent, selective, brain-penetrating T-type calcium channel blockers. Optimization focused mainly on solubility, brain penetration, and the search for an aminopyrazole metabolite that would be negative in an Ames test. This resulted in the preparation and complete characterization of compound 66b (ACT-709478), which has been selected as a clinical candidate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10368-35-1